Trimethoprim-Sulfamethoxazole (Septra,TMP/SMX)

C. diff Risk

Low

Oral Bioavailability

Excellent

Approximate Cost

~$0.20 / day

Dosing

No dosage adjustments available. Use with caution. Contraindicated in cases of marked hepatic damage.

General Information

Common Usage

  •  Urinary tract infections

  •  Susceptible MRSA infections

  •  Stenotrophomonas infections

  •  Pneumocystis jirovecii pneumonia (Treatment or prophylaxis)

Drug Monitoring

Follow creatinine and electrolytes in patients at increased risk renal failure, hyperkalemia.

Adverse Effects

  •  Gastrointestinal upset common

  •  Bone marrow suppression

  •  Hyperkalemia

  •  Renal failure

  •  Hepatitis

  •  Aseptic meningitis

  •  Stevens Johnson syndrome/toxic epidermal necrolysis

  •  Other rashes

Major Interactions

  • ACEi - Increased serum potassium level

  • Increases amantadine levels

  • Decreases cyclosporine

  • Methotrexate - Marrow suppression

  • Increases phenytoin

  • Increases rifampin

  • Increases INR with warfarin

Pharmacology

Antimicrobial class: Sulfonamide - Antifolate

Pregnancy category: C

Average serum half life: 10 hours

Urine penetration: Therapeutic

Lung penetration: Therapeutic

CSF penetration: Therapeutic

Biliary penetration: Moderate